IRIS
SAMMARTINO, JOSE' CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.625
AS - Asia 1.617
EU - Europa 1.115
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 84
OC - Oceania 1
Totale 5.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.482
CN - Cina 446
SG - Singapore 417
VN - Vietnam 237
HK - Hong Kong 229
RU - Federazione Russa 213
IT - Italia 205
BR - Brasile 163
DE - Germania 154
IE - Irlanda 150
FI - Finlandia 94
FR - Francia 84
CA - Canada 72
GB - Regno Unito 70
BD - Bangladesh 60
IN - India 53
ZA - Sudafrica 49
JP - Giappone 35
ES - Italia 27
MX - Messico 23
PL - Polonia 22
TR - Turchia 22
SE - Svezia 20
NL - Olanda 19
PK - Pakistan 16
IQ - Iraq 14
AT - Austria 13
ID - Indonesia 13
PH - Filippine 13
AR - Argentina 11
VE - Venezuela 11
IL - Israele 10
SA - Arabia Saudita 10
CO - Colombia 9
EC - Ecuador 9
JM - Giamaica 8
TT - Trinidad e Tobago 8
MY - Malesia 7
CL - Cile 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
HN - Honduras 6
TN - Tunisia 6
UZ - Uzbekistan 6
CH - Svizzera 5
GT - Guatemala 5
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
BE - Belgio 4
EG - Egitto 4
GP - Guadalupe 4
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
PY - Paraguay 4
SC - Seychelles 4
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
DK - Danimarca 2
HR - Croazia 2
JO - Giordania 2
KR - Corea 2
LB - Libano 2
OM - Oman 2
PR - Porto Rico 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
KW - Kuwait 1
LC - Santa Lucia 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NP - Nepal 1
Totale 5.662
Salva come PNG Salva come JPEG
Città #
San Jose 383
Ashburn 239
Singapore 230
Hong Kong 225
Dallas 193
Council Bluffs 155
Dublin 142
Beijing 134
Chandler 121
New York 105
Ho Chi Minh City 88
Munich 84
Los Angeles 73
Boardman 72
Helsinki 65
Lauterbourg 54
Santa Clara 53
Shanghai 52
Hanoi 50
Johannesburg 40
Columbus 34
Moscow 32
Milan 30
Redondo Beach 29
Turku 29
The Dalles 27
Pavia 25
Tokyo 24
Orem 23
Princeton 23
Denver 22
Toronto 21
Rome 20
Buffalo 19
Lawrence 19
Medford 18
Montreal 18
Chicago 17
Phoenix 17
Warsaw 17
Frankfurt am Main 16
Seattle 15
Stockholm 15
São Paulo 15
Wilmington 15
Brooklyn 14
Chennai 13
North Bergen 13
Amsterdam 11
Biên Hòa 11
Boston 11
Da Nang 11
Houston 11
Poplar 11
Atlanta 10
Charlotte 10
Mexico City 10
Nuremberg 10
Düsseldorf 9
Haiphong 9
London 9
Washington 9
Ann Arbor 8
Lecce 8
Baghdad 7
Bologna 7
Changsha 7
Hangzhou 7
Hải Dương 7
Manchester 7
Mumbai 7
Nanjing 7
Naples 7
Shenyang 7
Ankara 6
Belo Horizonte 6
Brasília 6
Falkenstein 6
Figino 6
Jakarta 6
Lahore 6
Tashkent 6
Utrera 6
Dhaka 5
Istanbul 5
New Delhi 5
San Francisco 5
San José 5
Cairo 4
Dearborn 4
Florence 4
Guatemala City 4
Honolulu 4
Jeddah 4
Karachi 4
Kingston 4
Medellín 4
Nanchang 4
Olomouc 4
Ottawa 4
Totale 3.493
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 174
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 147
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 145
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 141
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 134
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 131
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 128
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 124
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 123
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 122
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 122
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 120
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 118
Targeting iron uptake pathway for the development of novel antitubercular drugs. 115
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients 112
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 111
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 110
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 109
First triclosan-based macrocyclic inhibitors of InhA enzyme 109
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 109
Macrophages and monocytes: “trojan horses” in covid-19 105
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 104
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 103
Immunity to SARS-CoV-2 up to 15 months after infection 99
Effect of different surface treatments on titanium dental implant micro-morphology 99
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 98
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 97
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients 96
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 96
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 93
The 2023 dengue outbreak in Lombardy, Italy: A one-health perspective 92
Comparative analysis of the chemical composition and microstructure conformation between different dental implant Bone Drills 90
Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses 90
Clinical Influence of Micromorphological Structure of Dental Implant Bone Drills 89
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 87
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital 86
Effect of different titanium dental implant surfaces on human adipose mesenchymal stem cell behavior. An in vitro comparative study 86
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 86
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 85
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 84
Annotation process, guidelines and text corpus of small non-coding RNA molecules: The MiNCor for microRNA annotations 83
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 83
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 81
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors 79
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 79
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? 77
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 75
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19 75
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 74
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 74
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients 74
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 69
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment 67
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 67
P146 New weapons are necessary to fight Mycobacterium abscessus 63
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 61
Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts 60
White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds 58
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant 49
Fitness cost of rifampin resistance in Neisseria meningitidis: In Vitro study of mechanisms associated with rpoB H553Y mutation 46
Selection of Functional Glycoforms in Anti-SARS-CoV-2 Human IgG1 Monoclonal Antibodies by FcγRIIIa Affinity Chromatography and Mass Spectrometry 35
Totale 5.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 0 0 1 1 3 6 6 12 11 50
2022/2023448 32 40 3 29 27 24 0 16 240 13 21 3
2023/2024477 44 90 32 23 38 126 35 24 2 16 12 35
2024/20251.126 28 68 15 22 24 76 73 51 278 74 164 253
2025/20262.728 195 161 285 334 308 108 589 154 241 160 112 81
2026/2027799 83 153 129 276 158 0 0 0 0 0 0 0
Totale 5.798